搜索临床试验以:ACEI/血管紧张素转换酶抑制剂
总计47010个结果
-
Imperial College LondonBritish Heart Foundation; Institut de Recherches Internationales Servier未知
-
Vanderbilt UniversityNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
The George InstituteByrraju Foundation; The Future Forum, UK完全的
-
Yonsei UniversityChonbuk National University Hospital; Seoul St. Mary's Hospital; Kyungpook National University... 和其他合作者未知
-
Anna Posadzy-Małaczyńska完全的高血压 | 绝经 | 高尿酸血症
-
Hennepin Healthcare Research InstituteAmerican Heart Association完全的
-
Shenzhen Ausa Pharmed Co.,LtdPeking University First Hospital; Nanfang Hospital of Southern Medical University; Second Affiliated... 和其他合作者未知
-
Sohag University招聘中血管紧张素转换酶 rs (1799752) 基因多态性与稳定性冠状动脉疾病患者支架内再狭窄的发生埃及
-
NYU Langone HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Michigan 和其他合作者完全的
-
Heidelberg UniversityBaxter Healthcare Corporation; Boehringer Ingelheim; Aventis Pharmaceuticals; European Commission完全的高血压 | 孩子们 | 慢性肾功能衰竭 | Acquired Kidney Disease | Congenital Kidney Disease捷克共和国, 法国, 德国, 匈牙利, 意大利, 立陶宛, 波兰, 葡萄牙, 塞尔维亚, 瑞典, 瑞士, 火鸡
-
The University of The West IndiesCaribbean Health Research Council未知
-
Menarini International Operations Luxembourg SA完全的
-
Novartis Pharmaceuticals终止Non-diabetic Nephropathy荷兰
-
AHEPA University HospitalAristotle University Of Thessaloniki未知
-
Istituto Auxologico ItalianoEuropean Society of Hypertension; Chinese Hypertension League完全的
-
TSH Biopharm Corporation Limited完全的
-
Bispebjerg HospitalUniversity of Copenhagen; Duke University; The Ministry of Science, Technology and Innovation,... 和其他合作者完全的
-
Ministry of Health, Labour and Welfare, Japan未知
-
University of Maryland, BaltimoreKing Pharmaceuticals is now a wholly owned subsidiary of Pfizer终止